Masters Pharmaceuticals focuses on the international supply of licensed drugs into unlicensed territories, providing access to medicines commonly available in the US and Europe but hard to obtain elsewhere. The company also conducts specialist wholesale distribution of generic and branded pharmaceuticals. Masters serves core markets in Latin America, the Middle East and the Caribbean and plans to use new funding to expand further in those regions and to open markets in Asia. The firm is based in Elstree, UK. Recent financing will support its geographic expansion and commercial activities. The company strengthened its board with the appointment of Bill Burns as non‑executive chairman; he brings over 40 years of sector experience and was most recently CEO of Roche Pharmaceuticals.

Total raised

$4M

Funding rounds

1

Latest round

Equity

Latest activity

Jul 2010